KP
Kaveri Pohlman Clear Street Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
8.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $20 |
25%
upside
| 1 | +1.4% |
0
%
| 6 Mar ‘26 4 days ago |
|
|
|
Hold
Downgraded
| $58 | – | 3 | +15% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Hold
Downgraded
| $12 |
14%
downside
| 2 | -60% |
0
%
| 20 Jan ‘26 1 month ago |
|
|
|
Buy
Initiated
| $12 |
542%
upside
| 1 | -25% |
0
%
| 30 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $99 |
66%
upside
| 1 | -16% |
0
%
| 9 Dec ‘25 3 months ago |
|
|
|
Buy
Initiated
| $200 |
42%
upside
| 1 | +49% |
0
%
| 5 Dec ‘25 3 months ago |
|
|
|
Buy
Initiated
| $25 |
66%
upside
| 1 | +23% |
0
%
| 25 Nov ‘25 3 months ago |
|
|
|
Buy
Maintained
| $21 |
80%
upside
| 1 | -2.5% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Buy
Initiated
| $18 |
153%
upside
| 1 | +55% |
0
%
| 13 Nov ‘25 3 months ago |
|
|
|
Buy
Initiated
| $29 |
420%
upside
| 1 | -28% |
0
%
| 22 Oct ‘25 4 months ago |
|
|
|
Buy
Initiated
| $11 | – | 1 | +350% |
0
%
| 1 Oct ‘25 5 months ago |
|
|
|
Buy
Maintained
| $46 |
33%
upside
| 1 | +80% |
0
%
| 17 Sep ‘25 5 months ago |
|
|
|
Buy
Initiated
| $32 |
20%
upside
| 1 | +15% |
0
%
| 25 Jun ‘25 8 months ago |
|